chronic obstructive pulmonary disease
Conditions
Interventions
Placebo group:According to the GOLD2011 recommended by the stability of the treatment program for treatment
At the same time, take YIqigubiao pill agent Simulation 10 each time, 3 times a day, 12 weeks.
Yiqigubiao pill group:According to the GOLD2011 recommended by the stability of the treatment program for treatment
At the same time, take YIqigubiao pill 10 each time, 3 times a day, 12 weeks
Sponsors
Traditional Chinese medicine hospital of Xinjiang Uygur Autonomous Region
Eligibility
Sex/Gender
All
Age
40 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Patients corresponding to diagnosis standards of stable COPD; (2) Patients corresponding to diagnosis standards of Fei-Pi Qi-Deficiency Syndrome; (3) Age from 40-75 years; (4) The survival period was more than 3 months; (5) Good compliance with the consent of the test, and signed informed consent.
Exclusion criteria
Exclusion criteria: (1) Patients with Bronchial asthma, pulmonary tuberculosis, pulmonary tuberculosis, pulmonary cystic fibrosis, lung cancer, pulmonary abscess, congestive heart failure and other diseases; (2) Patients with serious cardiovascular, primary disease of liver, kidney, hematopoietic system; (3) Women in stage of pregnant or lactation; and Patients with psychosis; (4) Disabled patients (blind, deaf, mental retardation, physical disability); (5) People with multiple drug allergy of the test drug; patients with contraindications; (6) Patients with tumors; (7) People with congenital or acquired immunodeficiency; (8) Patients participate in other clinical trials in the recent month.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| TCM symptom mark;COPD assessment test, CAT;Plasma proteomics research; | — |
Secondary
| Measure | Time frame |
|---|---|
| Pulmonary Function;the times and severity of exacerbation; | — |
Countries
China
Contacts
Public ContactGao zhen
Outcome results
None listed